AI Article Synopsis
Article Abstract
Introduction: To evaluate the clinical benefit of preoperative adrenergic α1-antagonist therapy in the management of upper urinary calculi.
Materials And Methods: Publications were searched for The Cochrane Central Register of Controlled Trials, EMBASE, and MEDLINE until 1 March 2022 that related to the adrenergic α1- antagonist intake as adjunctive therapy before retrograde surgery. Dichotomous data were reported with risk ratios (RR) with 95% confidence intervals (CIs) and the continuous data were reported with mean difference (MD) with 95% CIs.
Results: There were nine studies with 867 patients included in this meta-analysis. Preoperative adrenergic α1- antagonists could significantly elevate the compared with the placebo. Higher successful access rate to the stone was found in patients who received preoperative adrenergic α1- antagonists than those who received the placebo (RR 1.24; 95% CI 1.17-1.33). Besides, the application of preoperative adrenergic α1- antagonists can also elevate 4th-week stone-free rate (RR 1.20; 95% CI 1.12-1.28), decrease postoperative analgesia (RR 0.30;95% CI 0.20-0.46) and result in a lower risk of overall complications (RR 0.38; 95% CI 0.24-0.61).
Conclusion: Preoperative adjunctive adrenergic α1- antagonist therapy is effective and safe in the management of retrograde surgery with a higher successful access rate and lower risk of severe complications.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9849750 | PMC |
| http://dx.doi.org/10.3389/fsurg.2022.1055904 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Development and evaluation of buccoadhesive propranolol hydrochloride tablet formulations: effect of fillers.
Farmaco
February 2004
Department of Pharmaceutics, Faculty of Pharmacy, Mazandaran(Sari) Medical Sciences University, Sari, Iran.
The buccal mucosa has been investigated for local and systemic delivery of therapeutic peptides and other drugs that are subjected to first-pass metabolism or are unstable within the rest of the gastrointestinal tract. Propranolol hydrochloride (propranolol HCl) is subjected to first-pass effect, therefore formulation of buccal-adhesive dosage form can circumvent this effect. The effect of lactose (a soluble excipient) and dicalcium phosphate (DCP) (an insoluble excipient) on dissolution rate, kinetic of release and adhesion force of buccal-adhesive tablets of propranolol HCl were evaluated.
View Article and Find Full Text PDFEffect of salmeterol on allergen-induced airway inflammation in mild allergic asthma.
Clin Exp Allergy
March 2001
Centre de Recherche de l'Hôpital Laval, Institut Universitaire de Cardiologie et de Pneumologie de l'Université Laval, 2725, chemin Sainte-Foy, Sainte-Foy, Québec, Canada G1V 4G5.
A previous study suggested that the long-acting beta2-adrenergic agonist salmeterol (SM) had inhibitory effects on bronchial mucosal inflammation 6 hours after allergen exposure. To further evaluate the influence of SM on allergen-induced airway inflammation. We studied, in a randomized, double-blind, cross-over trial, 16 mild asthmatic patients who had a dual asthmatic response to allergen inhalation.
View Article and Find Full Text PDF[The role of arachidonic acid derivatives in generating membrane potential oscillations of the rat aorta endothelium].
Fiziol Zh (1994)
May 2000
A. A. Bogomoletz Institute of Physiology, National Academy of Science of Ukraine, Kiev.
Involvement of metabolites of arachidonic acid in electrical responses of rat aortic endothelium evoked by the agonist of aa1-adrenoreceptors, phenylephrine has been investigated. Our experiments suggest that phenylephrine evokes synthesis of thromboxane A2 in the rat aorta that is involved in the phenylephrine-evoked oscillations probably by increasing excitatory effect of the vasoconstrictor on vascular smooth muscle by the mechanism of positive feedback.
View Article and Find Full Text PDFEffect of the leukotriene receptor antagonist pranlukast on cellular infiltration in the bronchial mucosa of patients with asthma.
Thorax
October 1998
Second Department of Internal Medicine, Toho University School of Medicine, Tokyo, Japan.
Background: It has been reported that pranlukast reduces the antigen induced immediate and late phase asthmatic responses, airway hyperreactivity to acetylcholine, and pulmonary eosinophil accumulation in guinea pigs. A study was undertaken to test the hypothesis that pranlukast may reduce the number of inflammatory cells in the bronchial mucosa of patients with asthma.
Methods: A double blind, placebo controlled study was performed in 17 mild to moderate asthmatic subjects to examine changes in inflammatory cell infiltration in response to pranlukast (225 mg orally twice per day for four weeks).
Effects of ketotifen on symptoms and on bronchial mucosa in patients with atopic asthma.
Allergy
August 1997
Second Department of Internal Medicine, Toho University School of Medicine, Tokyo, Japan.
Ketotifen is marketed throughout the world as an antiallergy drug, but whether it affects infiltration of inflammatory cells into airway mucosa is not known. We studied the effects of ketotifen on symptoms, pulmonary function, and airway inflammation in 25 patients with atopic asthma. Patients took ketotifen (1 mg twice daily) or a matching placebo for 8 weeks in a double-blind, parallel-group study.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!